Prescription of individual classes of medications to patients in the CVD/high CVD risk subgroup by gender and age group
| Total CVD/high CVD risk subgroup | 35–54 years | 55–64 years | ≥65 years | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | Women 6202 (47%) n (%) | Men 7091 (53%) n (%) | p Value | Women 874 (44%) n (%) | Men 1107 (56%) n (%) | p Value | Women 1417 (43%) n (%) | Men 1887 (57%) n (%) | p Value | Women 3911 (49%) n (%) | Men 4097 (51%) n (%) | p Value |
| Blood pressure medication | 4975 (80.2) | 5538 (78.1) | 0.003 | 578 (66.1) | 789 (71.3) | 0.01 | 1090 (76.9) | 1426 (75.6) | 0.37 | 3307 (84.6) | 3323 (81.1) | <0.001 |
| Statin | 4088 (65.9) | 4820 (68.0) | 0.01 | 505 (57.8) | 749 (67.7) | <0.001 | 986 (69.6) | 1293 (68.5) | 0.51 | 2597 (66.4) | 2778 (67.8) | 0.18 |
| Antiplatelet | 3312 (53.4) | 4071 (57.4) | <0.001 | 411 (47.0) | 618 (55.8) | <0.001 | 701 (49.5) | 1034 (54.8) | 0.002 | 2200 (56.3) | 2419 (59.0) | 0.01 |
| Anticoagulant | 469 (7.6) | 563 (7.9) | 0.42 | 27 (3.1) | 30 (2.7) | 0.62 | 49 (3.5) | 76 (4.0) | 0.40 | 393 (10.0) | 457 (11.2) | 0.11 |
CVD, cardiovascular disease.